Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Convertible Debt (2016 - 2018)

Historic Convertible Debt for Xtant Medical Holdings (XTNT) over the last 6 years, with Q1 2018 value amounting to $76.7 million.

  • Xtant Medical Holdings' Convertible Debt rose 5009.02% to $76.7 million in Q1 2018 from the same period last year, while for Mar 2018 it was $76.7 million, marking a year-over-year increase of 5009.02%. This contributed to the annual value of $70.9 million for FY2017, which is 4090.51% up from last year.
  • Latest data reveals that Xtant Medical Holdings reported Convertible Debt of $76.7 million as of Q1 2018, which was up 5009.02% from $70.9 million recorded in Q4 2017.
  • Over the past 5 years, Xtant Medical Holdings' Convertible Debt peaked at $76.7 million during Q1 2018, and registered a low of $44.2 million during Q4 2015.
  • For the 4-year period, Xtant Medical Holdings' Convertible Debt averaged around $62.9 million, with its median value being $67.3 million (2015).
  • In the last 5 years, Xtant Medical Holdings' Convertible Debt tumbled by 2321.2% in 2017 and then skyrocketed by 5009.02% in 2018.
  • Quarter analysis of 4 years shows Xtant Medical Holdings' Convertible Debt stood at $44.2 million in 2015, then rose by 13.68% to $50.3 million in 2016, then skyrocketed by 40.91% to $70.9 million in 2017, then increased by 8.18% to $76.7 million in 2018.
  • Its last three reported values are $76.7 million in Q1 2018, $70.9 million for Q4 2017, and $63.3 million during Q2 2017.